Why did 4570.T stock jump intraday today?

The intraday jump to **JPY 1,676.00** was driven by pre-earnings positioning and higher buying toward the session high of **JPY 1,700.00**. Volume picked up and traders priced in potential upside ahead of the **12 Feb 2026** earnings release.

How does valuation look for 4570.T stock?

Valuation is elevated: **PE 48.92**, **PB 9.43**, and **price-to-sales 15.44**. High margins and strong ROE support the premium, but valuations amplify downside if growth slows or guidance disappoints.

What is Meyka AI’s outlook for 4570.T stock?

Meyka AI's forecast model projects a monthly target of **JPY 1,758.89** (implied **+4.95%** upside from **JPY 1,676.00**). These are model-based projections and not guarantees; they should be used with other research.

What key risks should investors watch in 4570.T stock?

Watch earnings delivery, inventory cycle (days inventory **402.87**), and valuation multiple re-rating. Also monitor cash conversion and any change in demand for research reagents and biomarker services.

JP Stocks

4570.T Immuno-Biological (JPX) up 12.03% intraday 28 Jan 2026: earnings catalyst

ByHuzaifa Zahoor January 28, 2026

The 4570.T stock climbed 12.03% to JPY 1,676.00 intraday on 28 Jan 2026 on the JPX, led by stronger volume and a run toward the session high of JPY 1,700.00. Traders cite an earnings calendar catalyst and renewed interest in specialty reagents. The move followed an opening price of JPY 1,508.00 and lifted market cap to about JPY 15.61B. We examine valuation, technicals, Meyka grades, and what the Meyka AI forecast implies for near-term targets.